APA

Takenaka T., Shirakawa S., Mikuni C., Sai T., Shimamoto Y., Araki K., Hirano M., Miura A., Ohno Y., Ichimaru M., Hanada S., Inaba S., Konishi H., Toki H., Tajima K., Niimi M., Fukuda H. & Shimoyama M. (20000127). Alternating combination chemotherapy COP (cyclophosphamide, vincristine, prednisone) and MP (melphalan, prednisone) in multiple myeloma: a multicenter phase II study (JCOG8906). Lymphoma Study Group of the Japan Clinical Oncology Group. : Japanese journal of clinical oncology.

Chicago

Takenaka T, Shirakawa S, Mikuni C, Sai T, Shimamoto Y, Araki K, Hirano M, Miura A, Ohno Y, Ichimaru M, Hanada S, Inaba S, Konishi H, Toki H, Tajima K, Niimi M, Fukuda H and Shimoyama M. 20000127. Alternating combination chemotherapy COP (cyclophosphamide, vincristine, prednisone) and MP (melphalan, prednisone) in multiple myeloma: a multicenter phase II study (JCOG8906). Lymphoma Study Group of the Japan Clinical Oncology Group. : Japanese journal of clinical oncology.

Harvard

Takenaka T., Shirakawa S., Mikuni C., Sai T., Shimamoto Y., Araki K., Hirano M., Miura A., Ohno Y., Ichimaru M., Hanada S., Inaba S., Konishi H., Toki H., Tajima K., Niimi M., Fukuda H. and Shimoyama M. (20000127). Alternating combination chemotherapy COP (cyclophosphamide, vincristine, prednisone) and MP (melphalan, prednisone) in multiple myeloma: a multicenter phase II study (JCOG8906). Lymphoma Study Group of the Japan Clinical Oncology Group. : Japanese journal of clinical oncology.

MLA

Takenaka T, Shirakawa S, Mikuni C, Sai T, Shimamoto Y, Araki K, Hirano M, Miura A, Ohno Y, Ichimaru M, Hanada S, Inaba S, Konishi H, Toki H, Tajima K, Niimi M, Fukuda H and Shimoyama M. Alternating combination chemotherapy COP (cyclophosphamide, vincristine, prednisone) and MP (melphalan, prednisone) in multiple myeloma: a multicenter phase II study (JCOG8906). Lymphoma Study Group of the Japan Clinical Oncology Group. : Japanese journal of clinical oncology. 20000127.